Mark Christianson, Market Development Director at NEUROONE MEDICAL TECHNOLOGIES, sold NMTC on Jun 30, 2026
Data as of Oct 16
▼ SELL$31.8K10,000 shares at $3.18Mark Christianson Market Development DirectorNMTC NEUROONE MEDICAL TECHNOLOGIES Corp
- Traded
- Jun 30, 2026
- Disclosed
- Jul 2, 2026
- Filed
- 2 days after the trade
Form 4s are due within two business days.
Official filing (SEC Form 4) ↗
The price around the disclosure
NMTC since disclosure
−68.0%
after the sale
Similar stocks (XLV) since disclosure
+7.9%
XLV — its sector index fund
Change in closing price from Jul 2, 2026 (the first trading day on or after disclosure) to Oct 16, 2026. Dividends excluded. Not a return anyone earned.
Our take
None of our tested rules fired on this trade.